HB-WIN 2024 VQ Biomedical Series, a series of HB-WIN LLC — Form D
HB-WIN 2024 VQ Biomedical Series, a series of HB-WIN LLC of CARY, NC, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2024-12-27. The offering totals $610K, of which $555K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2024-12-27
- Form: D
- Accession: 0002022031-24-000004
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $610K
- Amount sold: $555K
- Remaining: $55K
- Minimum investment: $5K
- Investors: 36
- Date of first sale: 2024-10-22
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-533527
Issuer
- Name: HB-WIN 2024 VQ Biomedical Series, a series of HB-WIN LLC
- CIK: 0002050196
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 107 KILMAYNE DRIVE, CARY, NC, 27511
- Phone: 919-612-0729
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| John Michael Harlow | Director | Clayton, NC |
| John Powell Leachman | Director | Gainesville, GA |
| Robert Earl Ross | Director | Cary, NC |
| John Powell Leachman | Promoter | Gainesville, GA |
| Robert Earl Ross | Promoter | Cary, NC |
More